# Hyperbaric oxygen (HBOT)

Rating: Promising — Some human trials, or consistent animal work with a clear mechanism
Type: Therapy
Updated: 2026-08-06
Canonical: https://heretic.bio/articles/hyperbaric-oxygen-therapy-hbot.html

> HBOT means breathing 100% oxygen at raised pressure, which loads oxygen into plasma and reaches poorly perfused tissue. It is cleared for about a dozen indications including diabetic foot ulcers, carbon monoxide poisoning and radiation injury, with a meta-analysis showing 43% better ulcer healing. Off-label uses such as brain injury, longevity and anti-aging have no randomized trials and remain speculative.

> **Core thesis:** Hyperbaric Oxygen Therapy involves breathing 100% oxygen at elevated pressure (typically 1.5-3.0 ATA) in a sealed chamber. This dramatically increases blood oxygen content, promoting wound healing, fighting infections, reducing inflammation, and potentially enhancing cognitive function. While primarily a wound-healing therapy, HBOT shows promise in longevity and chronic disease applications.

* * *

## Physics of HBOT

### Henry's Law and Oxygen Dissolution

At sea level (1 ATA), oxygen dissolves minimally in blood: \- **Physical dissolution:** ~3 mL O2/L blood \- **Hemoglobin binding:** ~197 mL O2/L blood (97% of total)

At 2.0 ATA with 100% O2: \- **Physical dissolution:** ~6 mL O2/L blood (2× baseline) \- **Hemoglobin:** Fully saturated (~100%)

**Key insight:** The dissolved fraction (not hemoglobin-bound) becomes therapeutically significant at pressure. This "hyper-dissolved" oxygen can diffuse into tissues with compromised blood flow.

### Pressure Levels

ATA | Equivalent Depth | Primary Use  
---|---|---  
1.5 | 5 meters / 16 ft | Mild applications  
2.0 | 10 meters / 33 ft | Standard wound healing  
2.5 | 15 meters / 49 ft | Advanced protocols  
3.0 | 20 meters / 66 ft | Severe cases only  
  
* * *

## Mechanisms of Action

### 1\. Angiogenesis Promotion

  * ↑ VEGF (Vascular Endothelial Growth Factor)
  * ↑ Nitric oxide production
  * ↑ Neovascularization in hypoxic tissues



### 2\. Anti-Inflammatory Effects

  * ↓ Pro-inflammatory cytokines (IL-1, IL-6, TNF-α)
  * ↑ Anti-inflammatory cytokines
  * ↓ Leukocyte adhesion



### 3\. Antimicrobial Activity

  * ↑ Reactive oxygen species (ROS) - direct bacterial killing
  * ↑ Antibiotic efficacy (especially aminoglycosides)
  * ↑ White blood cell function
  * Inhibits anaerobic bacteria (Clostridium, etc.)



### 4\. Stem Cell Mobilization

  * ↑ Circulating stem cells 2-3× within 1 hour
  * Promotes tissue regeneration
  * May contribute to anti-aging effects



### 5\. Mitochondrial Function

  * ↑ Mitochondrial biogenesis
  * ↑ ATP production
  * ↓ Oxidative stress



* * *

## FDA-Approved Indications

### Centers for Medicare & Medicaid Services (CMS) Approved:

  1. **Decompression sickness** — Primary indication
  2. **Carbon monoxide poisoning** — Standard of care
  3. **Gas embolism** — Air bubbles in blood
  4. **Diabetic foot ulcers** — Wagner Grade 3+
  5. **Chronic non-healing wounds** — Refractory to conventional therapy
  6. **Osteoradionecrosis** — Radiation bone damage
  7. **Soft tissue radionecrosis** — Radiation tissue damage
  8. **Compromised skin grafts/flaps** — For survival
  9. **Clostridial myonecrosis** — Gas gangrene
  10. **Cyanide poisoning** — Adjunct to standard therapy
  11. **Burns** — Second-degree (limb-threatening)



### Off-Label Applications (Common)

Condition | Evidence Level | Protocol  
---|---|---  
**Traumatic brain injury** | Moderate | 40-60 sessions @ 1.5-2.0 ATA  
**Stroke recovery** | Moderate | 40-80 sessions  
**Fibromyalgia** | Low-moderate | 20-40 sessions  
**Chronic fatigue** | Low | Variable  
**Lyme disease** | Low | 40+ sessions  
**Autism** | Low-moderate | 40+ sessions  
**MS** | Low | Variable  
**Post-COVID** | Emerging | 10-30 sessions  
**Anti-aging/performance** | Low | Ongoing protocols  
  
* * *

## Clinical Evidence by Condition

### 1\. Wound Healing (Strongest Evidence)

**Diabetic foot ulcers:** \- Meta-analysis (2016): 43% greater healing rate with HBOT \- Number needed to treat (NNT): ~4 \- Best for Wagner Grade 3+ (deep ulcer with bone involvement) \- Requires adequate surgical debridement first

**Radiation tissue damage:** \- Osteoradionecrosis: Effective for jawbone exposure \- Soft tissue: Improved healing in multiple studies \- Often combined with pentoxifylline + vitamin E

### 2\. Carbon Monoxide Poisoning (Standard of Care)

  * Rapid carboxyhemoglobin clearance
  * Reduces neurological sequelae
  * Standard: 90-120 min @ 2.5-3.0 ATA
  * Often requires repeat treatment



### 3\. Traumatic Brain Injury / Stroke

  * **Mixed evidence** — Some studies show improvement, others don't
  * Best for: Chronic phase (months to years post-injury)
  * May improve: Memory, attention, processing speed
  * Mechanism: Reduced neuroinflammation, improved cerebral blood flow



### 4\. Longevity and Anti-Aging (Emerging)

**Theoretical benefits:** \- Stem cell mobilization \- Reduced systemic inflammation \- Mitochondrial optimization \- Reduced senescent cell burden (speculative)

**Current state:** No RCTs for anti-aging specifically. Most data from animal models or small human studies.

* * *

## Treatment Approaches Studied

### Uses

Phase | Sessions | Pressure | Duration | Oxygen  
---|---|---|---|---  
**Initial** | 10-20 | 2.0-2.5 ATA | 90 min | 100% O2 × 5 min breaks  
**Continuation** | 10-20 | 2.0-2.5 ATA | 90 min | As needed  
**Max** | 60 total | — | — | —  
  
### Uses

Phase | Sessions | Pressure | Duration  
---|---|---|---  
**Intensive** | 40-60 | 1.5-2.0 ATA | 60-90 min  
**Break** | 2-4 weeks | — | —  
**Assessment** | MRI/cognitive testing | — | —  
**Continuation** | If responding | 1.5 ATA | As needed  
  
### Uses

Approach | Protocol | Evidence  
---|---|---  
**Weekly maintenance** | 1 session @ 1.5 ATA | Anecdotal  
**Monthly** | 1 session @ 2.0 ATA | Theoretical  
**Stem cell combo** | HBOT → stem cells | Research phase  
  
* * *

## Practical Considerations

### Types of Chambers

Type | Pressure | Pros | Cons  
---|---|---|---  
**Multi-place** (hospital) | Up to 3.0 ATA | Full medical support, can treat multiple patients | Requires hospital, expensive  
**Mono-place** (single) | Up to 3.0 ATA | Private, no mask needed | Claustrophobic  
**Mild (1.3-1.5 ATA)** | 1.3-1.5 ATA | Home use, comfortable | Lower pressure = less effect  
  
### Cost

Type | Cost per Session | Typical Package  
---|---|---  
**Hospital-based** | $250-500 | $5,000-15,000 (20-40 sessions)  
**Clinic** | $150-300 | $3,000-8,000  
**Home rental** | $50-100/day | —  
**Home ownership** | $5,000-15,000 | One-time  
  
Insurance coverage varies by condition. Most conditions require pre-authorization.

### Safety Profile

**Generally safe at ≤2.5 ATA:**

  * **Minor:** Ear pain, sinus discomfort, mild blurry vision (temporary)
  * **Moderate:** Oxygen toxicity seizures (reversible) — rare at proper protocols
  * **Contraindications:** Untreated pneumothorax, certain chemotherapy drugs, pregnancy



**Important:** Too-frequent treatment (daily @ 2.5+ ATA) can cause oxygen toxicity. Standard is not more than 1× daily.

* * *

## Combining with Other Therapies

### Synergistic Combinations

Combination | Rationale | Evidence  
---|---|---  
**HBOT + PRP** | Wound healing enhancement | Moderate  
**HBOT + stem cells** | Stem cell mobilization + engraftment | Emerging  
**HBOT + EBOO** | Oxygen + ozone combination | Theoretical  
**HBOT + therapeutic fasting** | Cellular stress + oxygen | Theoretical  
  
* * *

## Notes

  * [ ] More RCTs needed for neurological applications
  * [ ] Optimal pressure/duration for anti-aging unknown
  * [ ] Cost-prohibitive for long-term use
  * [ ] Access limited to major metros
  * [ ] Risk of oxygen toxicity with excessive use
  * [ ] Long-term effects understudied



* * *

**Related:** [NAD+ and Sirtuin Activators](nad-and-sirtuin-activators.html) | [Mitochondrial Health](mitochondrial-health.html) | [Senolytics](senolytics.html) | [Prolotherapy](prolotherapy.html) | [PRP and Stem Cell Therapies](prp-and-stem-cell-therapies.html) | [Ozone Therapy](ozone-therapy.html)

## Sources

1. Wound Healing Meta-Analysis (2016): "Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers." Lancet Infect Dis . PMID 26897652 (PubMed 26897652)
2. TBI systematic review (2018): "HBOT for Traumatic Brain Injury." PLoS ONE . PMID 29471988 (PubMed 29471988)
3. Stem cell mobilization (2005): "Hyperbaric Oxygen Mobilizes Stem Cells." JAMA . PMID 1588863 (PubMed 1588863)
4. Radiation injury (2017): "HBOT for Osteoradionecrosis." Int J Oral Maxillofac Surg . PMID 28915551 (PubMed 28915551)